Plavix is an antiplatelet drug; specific and active inhibitor of platelet aggregation; has a coronary-dilating effect. The use of Plavix is indicated for the prevention of atherothrombotic complications in adult patients with myocardial infarction in adult patients with an acute coronary syndrome. The drug is also indicated to prevent atherothrombotic and thromboembolic complications, including a stroke, atrial fibrillation in patients with atrial fibrillation, who have at least one risk factor for vascular complications and who cannot take indirect anticoagulants and have a low risk of bleeding.

Zyloprim is a tablet the effect of which appears due to the mechanism of action of its basic component called Allopurinol. This medicine is prescribed as a treatment of hyperuricemia, primary and secondary gout, urolithiasis with the formation of urinary calculi, hemoblastoma, cytostatic and radiation therapy of tumors, psoriasis, traumatic toxicosis. It is used as a corticosteroid therapy for the prevention of urinary acid nephropathy, malignant neoplasms and congenital disorders of purine metabolism in children.